Detalles de la búsqueda
1.
CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice.
Int J Obes (Lond)
; 39(6): 977-85, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25771927
2.
Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung.
J Thromb Haemost
; 5(12): 2467-75, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17848179
3.
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Diabetes
; 49(8): 1374-80, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10923640
4.
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Thromb Haemost
; 87(2): 306-10, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11858492
5.
Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice.
J Thromb Haemost
; 12(6): 958-69, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24655755
6.
Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
J Pathol
; 214(5): 574-83, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18247429
7.
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet.
Diabetologia
; 50(6): 1267-76, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17426960
8.
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Diabetologia
; 44(11): 2025-31, 2001 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11719834
Resultados
1 -
8
de 8
1
Próxima >
>>